SA accelerates local COVID vaccine development for mutant strains
Date Posted – 13 May 2021 A leading South Australian immunologist has been awarded $3 million from the Federal Government to accelerate work on a locally developed Covid-19 vaccine, in what’s anticipated to be the second line of…
Awards Recognise Women Health Innovators
Date Posted – 13 May 2021 Four outstanding women have been recognised for their incredible work across Victoria’s health technology sector as Australia dealt with COVID-19 in 2020. Victoria’s medical and scientific communities made an important contribution to…
SeerPharma – MTP Connect : REDI Initiative QMS Training
Date Posted – 7 May 2021 SeerPharma has secured a project with MTP Connect –to deliver a range of training programs to early stage researchers and companies across Australia on Quality Management. If you’re interested in learning more,…
Imagion Biosystems and Patrys to Collaborate on Brain Tumor Imaging
Date Posted – 3 May 2021 Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, and Patrys Limited (ASX: PAB), a therapeutic antibody development company, are pleased to announce a…
New Director to Support COVID Vaccine Development at Sementis
Date Posted – 27 April 2021 Adelaide-based Australian biotechnology company Sementis has appointed internationally-renowned Dr Anna Lavelle as an Independent Director. Dr Lavelle was named among the world’s 100 most influential people in global life sciences by Scientific…
Victoria announces $50m to fund mRNA COVID-19 vaccine production in Australia, paving way for Pfizer-style manufacturing
Date Posted – 21 April 2021 The Victorian government is providing $50 million to “kickstart” domestic manufacturing of mRNA vaccine technology. It will take at least 12 months for any of the vaccines to be made in Australia,…
Mutiple Dose Part Of Ad-214 Phase I Trial Commenced – AdAlta
Date Posted – 19 April 2021 AdAlta Limited (ASX:1AD), the clinical stage biotechnology company developing novel medicines using its i-body platform is pleased to announce that the first cohort of healthy volunteers have received the first of three…
Launching Innovation Challenge with CSL Behring and Cicada Innovations
Date Posted – 14 April 2021 Applications Closed – 25 May 2021 Cicada Innovations and CSL Behring earlier today, launnched an Innovation Challenge to unearth solutions that will improve the production of Immunoglobulin G to meet growing global…
First Patients Benefit from Victoria’s Non-Invasive Gamma Knife
Date Posted – 8 April 2021 The first Gamma Knife to be installed in Victoria, at Peter MacCallum Cancer Centre, is now fully operational, with the first patients to receive the non-invasive radiosurgery sharing their experiences. The Gamma…
Vic government rolls out $50,000 grants for SMEs to adopt or develop innovative tech
Date Posted – 8 April 2021 Applicaitons Close – 19 April 2021 Victorian businesses can now apply for up to $50,000 in grant funding from the state government to put towards innovative tech projects. Launched this month, the…
Mr Peter Giannopoulos appointed as CEO of Cell Therapies Pty Ltd
Date Posted – 6 April 2021 Cell Therapies Pty Ltd, a leading provider of cell and gene therapy products in the Asia Pacific region, is delighted to announce the appointment of Mr Peter Giannopoulos as the company’s new Chief Executive…
Defence Science Institute Hazardous Agent Challenge
Date Posted – 1 April 2021 Submissions Close – 12 May 2021 Victoria’s Defence Science Institute is calling for proposals in support of a $1M initiative to advance the development of prototypes for enhanced resilience against chemical and…
